SK279136B6 - Hydrazóny, farmaceutické prípravky s ich obsahom a - Google Patents

Hydrazóny, farmaceutické prípravky s ich obsahom a Download PDF

Info

Publication number
SK279136B6
SK279136B6 SK1317-91A SK131791A SK279136B6 SK 279136 B6 SK279136 B6 SK 279136B6 SK 131791 A SK131791 A SK 131791A SK 279136 B6 SK279136 B6 SK 279136B6
Authority
SK
Slovakia
Prior art keywords
group
formula
compounds
pharmaceutically acceptable
hydrogen atom
Prior art date
Application number
SK1317-91A
Other languages
English (en)
Slovak (sk)
Inventor
Jaroslav Stanek
J�rg FREI
Giorgio Caravatti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK279136B6 publication Critical patent/SK279136B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
    • C07C337/08—Compounds containing any of the groups, e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/20—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/12—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Photolithography (AREA)
  • Wire Bonding (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1317-91A 1990-05-07 1991-05-06 Hydrazóny, farmaceutické prípravky s ich obsahom a SK279136B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH153890 1990-05-07

Publications (1)

Publication Number Publication Date
SK279136B6 true SK279136B6 (sk) 1998-07-08

Family

ID=4212764

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1317-91A SK279136B6 (sk) 1990-05-07 1991-05-06 Hydrazóny, farmaceutické prípravky s ich obsahom a

Country Status (26)

Country Link
EP (1) EP0456133B1 (fr)
JP (1) JP2565602B2 (fr)
KR (1) KR100203234B1 (fr)
AT (1) ATE119878T1 (fr)
AU (1) AU645799B2 (fr)
CA (1) CA2041832C (fr)
CY (1) CY2080B1 (fr)
CZ (1) CZ279340B6 (fr)
DE (1) DE59104930D1 (fr)
DK (1) DK0456133T3 (fr)
ES (1) ES2069768T3 (fr)
FI (1) FI107916B (fr)
GR (1) GR3015574T3 (fr)
HK (1) HK1000919A1 (fr)
HU (1) HU218221B (fr)
ID (1) ID1040B (fr)
IE (1) IE66157B1 (fr)
IL (1) IL98008A (fr)
NO (1) NO175097C (fr)
NZ (1) NZ238033A (fr)
PT (1) PT97571B (fr)
RU (2) RU2057748C1 (fr)
SA (1) SA91120283B1 (fr)
SK (1) SK279136B6 (fr)
TW (1) TW202428B (fr)
ZA (1) ZA913391B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395855A (en) * 1990-05-07 1995-03-07 Ciba-Geigy Corporation Hydrazones
RU2081108C1 (ru) * 1991-10-16 1997-06-10 Циба-Гейги АГ Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью
ATE133938T1 (de) * 1992-04-03 1996-02-15 Innothera Lab Sa Indan-1,3-dion und indan-1,2,3-trionderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
FR2710639B1 (fr) * 1993-10-01 1995-12-22 Innothera Lab Sa Dérivés d'indane cétoniques, leur procédé d'obtention, leur application thérapeutique.
ATE278676T1 (de) * 1995-01-26 2004-10-15 Novartis Pharma Gmbh Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
EP1408028A1 (fr) * 2002-10-09 2004-04-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Inhibition de la S-adenosyl methionine decarboxylase comme traitement des infections dues au Herpes simplex virus
EP1834669A1 (fr) * 2006-03-15 2007-09-19 Heinrich-Pette-Institut Utilisation de composés hydrazones pour traiter les infections virales
EP1884515A1 (fr) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Composés indanylsulfamides, leur préparation et utilisation comme médicament
CN102627593A (zh) * 2012-02-23 2012-08-08 河南师范大学 具有抗癌活性的1，4-二羟基-2-甲酰基-9，10蒽醌缩氨硫脲新化合物及制备方法
AU2015282901B2 (en) * 2014-07-02 2019-01-17 Inflectis Bioscience O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0377304B1 (fr) * 1988-12-27 1994-03-09 E.I. Du Pont De Nemours And Company Arthropodicides de semicarbazones substituées

Also Published As

Publication number Publication date
IE66157B1 (en) 1995-12-13
HU218221B (hu) 2000-06-28
EP0456133A1 (fr) 1991-11-13
NO911777D0 (no) 1991-05-06
CA2041832C (fr) 2002-09-17
CY2080B1 (en) 1998-10-16
TW202428B (fr) 1993-03-21
ES2069768T3 (es) 1995-05-16
ID1040B (id) 1996-10-25
KR910019964A (ko) 1991-12-19
JP2565602B2 (ja) 1996-12-18
SA91120283B1 (ar) 2005-12-17
IL98008A0 (en) 1992-06-21
RU2057748C1 (ru) 1996-04-10
NO175097B (no) 1994-05-24
NO175097C (no) 1994-08-31
JPH04225946A (ja) 1992-08-14
IE911530A1 (en) 1991-11-20
HUT57183A (en) 1991-11-28
GR3015574T3 (en) 1995-06-30
DK0456133T3 (da) 1995-05-22
FI107916B (fi) 2001-10-31
ZA913391B (en) 1991-12-24
EP0456133B1 (fr) 1995-03-15
CA2041832A1 (fr) 1991-11-08
KR100203234B1 (ko) 1999-06-15
PT97571B (pt) 1999-04-30
CZ279340B6 (cs) 1995-04-12
ATE119878T1 (de) 1995-04-15
NZ238033A (en) 1993-01-27
AU645799B2 (en) 1994-01-27
PT97571A (pt) 1992-01-31
FI912164A (fi) 1991-11-08
AU7596791A (en) 1991-11-07
HK1000919A1 (en) 1998-05-08
NO911777L (no) 1991-11-08
FI912164A0 (fi) 1991-05-03
CS131791A3 (en) 1992-03-18
RU2066311C1 (ru) 1996-09-10
DE59104930D1 (de) 1995-04-20
IL98008A (en) 1996-08-04

Similar Documents

Publication Publication Date Title
EP3054954A1 (fr) Inhibiteurs hdac, seuls ou en combinaison avec des inhibiteurs btk, pour traiter des lymphomes non-hodgkiniens
SK63294A3 (en) Organic salts of n,n'-diacetylcystine
SK279136B6 (sk) Hydrazóny, farmaceutické prípravky s ich obsahom a
US4452800A (en) Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
IL99237A (en) Preparation of a preparation in the form of a tablet or pill containing a compound sensitive to moisture, heat and light with a monoclinic crystal structure
SK284301B6 (sk) Použitie hydroxylamínového derivátu na liečenie alebo prevenciu poškodenia endotelových buniek
WO1989005637A1 (fr) Courbes de toxicite ameliorees en chimiotherapie
JP2515119B2 (ja) ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物
EP0617959A1 (fr) Médicament pour le traitement des maladies de la peau
US4148879A (en) Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4895851A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
EP0504290B1 (fr) Inhibiteurs de reductase de dihydrofolate de pneumocystis carinii
US4148878A (en) Inhibition of platelet aggregation with selected phosphoric acid esters
US5885993A (en) Remedy for pancreatitis
US3701829A (en) Treatment of parkinson's disease
US3714363A (en) Substituted amino guanidine as anti-diabetic agents
US5886000A (en) Anti-HIV agent
NZ235914A (en) Immunosuppressant pharmaceutical composition
CZ281691B6 (cs) Farmaceutický prostředek proti vysokému krevnímu tlaku
JPH0641408B2 (ja) 酵素阻害剤
CN109824574B (zh) 吲哚-3-甲酰胺类化合物及其应用
US3821409A (en) Method of treatment
KR20000005115A (ko) 이미다졸유도체를함유하는함유하는항-hiv조성물
US3723620A (en) 3-substituted amino-6-hydrazino pyridazines as hypotensives
US5747495A (en) Method for treating hypertension using pyrazolopyrimidine derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100506